Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2012; 18(7): 654-661
Published online Feb 21, 2012. doi: 10.3748/wjg.v18.i7.654
Figure 3
Figure 3 SKLB010 prevented the nuclear translocation of nuclear factor-κB by inhibiting degradation of IκB. A: The inhibition of nuclear factor-κB (NF-κB)-DNA binding. Carbon tetrachloride (CCl4)-mediated activation of NF-κB resulted in an increase in DNA-binding activity of NF-κB within 2 h, followed by inactivation of NF-κB at 6 h after stimulation which was demonstrated by a lower DNA-binding activity; B: SKLB010 inhibited the CCl4-induced degradation of IκB. Total tissue proteins were analyzed by Western blotting at different time points for IκB-α using specific IκB antibodies. β-actin was used as an internal control.